Brandinium

Trademark search for:

APTALIS

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2011-05-20 — Application filed
  • 2011-05-24 — Application filed
  • 2011-05-24 — Application filed
  • 2011-09-07 — Assigned to examiner
  • 2011-09-08 — Final disposition recorded
  • 2011-09-08 — Final disposition recorded
  • 2011-09-08 — Final disposition recorded
  • 2012-03-08 — Office action issued
  • 2012-03-08 — Correspondence received in law office
  • 2012-03-09 — Teas/email correspondence entered
  • 2012-04-10 — Final disposition recorded
  • 2012-04-10 — Final disposition recorded
  • 2012-04-10 — Final disposition recorded
  • 2012-04-11 — Automatic update of assignment of ownership
  • 2012-10-10 — Office action issued
  • 2012-10-10 — Correspondence received in law office
  • 2012-10-11 — Teas/email correspondence entered
  • 2012-11-01 — Suspension letter written
  • 2012-11-01 — Letter of suspension e-mailed
  • 2012-11-01 — Notification of letter of suspension e-mailed
  • 2013-05-01 — Suspension inquiry written
  • 2013-05-01 — Inquiry to suspension e-mailed
  • 2013-05-01 — Notification of inquiry as to suspension e-mailed
  • 2013-05-01 — Assigned to lie
  • 2013-09-09 — Teas response to suspension inquiry received
  • 2013-09-17 — Teas/email correspondence entered
  • 2013-09-17 — Correspondence received in law office
  • 2013-10-05 — Suspension letter written
  • 2013-10-05 — Letter of suspension e-mailed
  • 2013-10-05 — Notification of letter of suspension e-mailed
  • 2013-11-06 — Assignment of ownership not updated automatically
  • 2014-02-12 — Assignment of ownership not updated automatically
  • 2014-04-09 — Suspension inquiry written
  • 2014-04-09 — Inquiry to suspension e-mailed
  • 2014-04-09 — Notification of inquiry as to suspension e-mailed
  • 2014-09-16 — Attorney/dom.rep.revoked and/or appointed
  • 2014-09-16 — Teas revoke/app/change addr of atty/dom rep received
  • 2014-11-05 — Application abandoned
  • 2014-11-05 — Application abandoned
  • 2014-11-05 — Notice of unresponsive amendment - e-mailed
  • 2014-11-05 — Notification of notice of unresponsive amendment - e-mailed
  • 2014-11-05 — Report unresponsive amendment - completed
  • 2014-11-05 — Final status recorded
  • 2015-05-29 — Attorney/dom.rep.revoked and/or appointed
  • 2015-05-29 — Teas change of correspondence received
  • 2015-05-29 — Teas revoke/app/change addr of atty/dom rep received
  • 2015-06-02 — Teas petition to director received
  • 2015-07-06 — Assigned to petition staff
  • 2015-07-07 — Petition to director denied

Owner Information

APTALIS PHARMA CANADA INC.
MONT-SAINT-HILAIRE, QUEBEC CA
AXCAN PHARMA INC.
Quebec CA

Correspondent

Matthew O. Brady Aptalis Pharma Canada Inc., c/o Actavis, Inc.
400 Interpace Parkway
Morris Corporate Center III
Parsippany, NJ 07054

Filing Details

Filing Date:
2011-05-20
Status Date:
2014-11-05
Category:
Science & Technology Services
Filing Year:
2011

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.